Invention Grant
- Patent Title: Personalized medicine approach for treating cognitive loss
-
Application No.: US15037492Application Date: 2014-11-26
-
Publication No.: US11885816B2Publication Date: 2024-01-30
- Inventor: Sid E. O'Bryant
- Applicant: University of North Texas Health Science Center at Fort Worth
- Applicant Address: US TX Fort Worth
- Assignee: University of North Texas Health Science Center at Forth Worth
- Current Assignee: University of North Texas Health Science Center at Forth Worth
- Current Assignee Address: US TX Forth Worth
- Agency: Saul Ewing LLP
- Agent Domingos J. Silva
- International Application: PCT/US2014/067562 2014.11.26
- International Announcement: WO2015/081166A 2015.06.04
- Date entered country: 2016-05-18
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G16B40/00 ; C12Q1/6883 ; G16H50/20 ; G16B40/20 ; G16B40/30 ; G16H50/30
Abstract:
The present invention includes methods for selecting a therapy for improved cognition as well as prevention of cognitive loss/dysfunction using one or more endophenotypes comprising: obtaining a sample from a subject; measuring biomarkers that differentiate between an inflammatory, a metabolic, a neurotrophic, and a depressive endophenotype; and selecting a course of treatment for the subject based on whether the subject is scored as having a high or a low endophenotype for one or more of the inflammatory, a metabolic, a neurotrophic, and a depressive endophenotypes.
Public/Granted literature
- US20160291036A1 PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS Public/Granted day:2016-10-06
Information query
IPC分类:
